Amberstone Biosciences
Pre-clinicalAmberstone pioneers a next-gen tumor activated immunotherapeutics. While many promising immunotherapeutics show potent anti-tumor activity, their clinical application is often limited by harmful effects to healthy tissues. With our innovative T-MATE™ technology, we offer a precise solution that effectively triggers immune responses in tumors while sparing healthy tissues. Our approach safely unlocks the therapeutic potential of a multitude of immunotherapeutics that have been historically dee...
About
Amberstone pioneers a next-gen tumor activated immunotherapeutics. While many promising immunotherapeutics show potent anti-tumor activity, their clinical application is often limited by harmful effects to healthy tissues. With our innovative T-MATE™ technology, we offer a precise solution that effectively triggers immune responses in tumors while sparing healthy tissues. Our approach safely unlocks the therapeutic potential of a multitude of immunotherapeutics that have been historically dee...
Funding History
1Total raised: $12M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile